Other Events ·
On June 15, 2026, Genenta Science S.p.A. received notification from Nasdaq that it has regained compliance with…
GNTAGenenta Science S.p.A.
On June 15, 2026, Genenta Science S.p.A. received notification from Nasdaq that it has regained compliance with Listing Rule 5550(a)(2) regarding the minimum bid price requirement of $1.00 per share. This follows a previous non-compliance notice on April 10, 2026. Nasdaq confirmed that the closing bid price of the company's American Depositary Shares remained at or above $1.00 for 10 consecutive business days from June 1, 2026, through June 12, 2026. Genenta Science S.p.A. operates in the biotechnology industry, focusing on precision oncology and cancer research.